International Research journal of Management Science and Technology

  ISSN 2250 - 1959 (online) ISSN 2348 - 9367 (Print) New DOI : 10.32804/IRJMST

Impact Factor* - 6.2311


**Need Help in Content editing, Data Analysis.

Research Gateway

Adv For Editing Content

   No of Download : 144    Submit Your Rating     Cite This   Download        Certificate

EVALUATION OF A FORMULATED “FAROPENUM” A NEW BETA LACTUM CARBAPENUM

    2 Author(s):  BHOOMIKA CHAUDHARY, DR ROHIT SARASWAT

Vol -  11, Issue- 2 ,         Page(s) : 45 - 58  (2020 ) DOI : https://doi.org/10.32804/IRJMST

Abstract

The aim of the research is to use l-threonine as the material along with the formulation and evaluation of the new beta lactam antibiotic or can be called as the new carbapenum. The formulation was evaluated for the following effect of extended release polymer, effect of formula reproducibility, effect of pH of dissolution media on drug release and effect of storage under ICH accelerated conditions. It not only propagates the section but also works on the bacteria by inhibiting the synthesis of bacterial cell wall. The formulation is having the different pharmacokinetic property, effective in the treatment of various diseased conditions like: respiratory tract, urinary tract, ophthalmic, pulmonary, community acquired pneumonia, pyelonephritis, Acute bacterial sinusitis, Community acquired pneumonia, Acute exacerbations of chronic bronchitis, Uncomplicated skin and skin structure infection, Otitis externa, Sinusitis, Tympanitis, Prostatitis, Cystitis, Tonsillitis, Pharyngitis, Bartholin’s gland infection and adnexitis , Lymphangitis, Folliculitis, Pustular acne, Secondary infection of external wound or surgical wound, Subcutaneous abscesses.

1. Sheth, P.R. and Tossounian J.L., US Patent No. 4 ,  1979 140 :755
2.  Seng, C.H., J. Pharm. Sci. 1985, 74 (4) :399–405.
3. Park, K., Robinson, J.R., Int. J. Pharm. 1984, 19 (1): 107–127.
4.  Russel J., Bass P., Gastroenterology 1985, 89:307-315.
5.  Lehr, C.M. and Hass, J., Expert Opinion on Biological Therapy 2002, 2: 287–298
6. Smart, J.D., Kellaway, I.W., Int. J. Pharm. 1989, 53: 79–83.
7. Sakkinen, M., Linna, A., Ojala, S., Jurjenson, H., Veski, P., Marvola, M. Int. J. Pharm. 2003, 250 (1): 227–237.
8. Caldwell, L.J., Gardner, C.R., and Cargill, R.C., US Patent No. 4, April 1988 :735, 804 
9.  Gupta, P., Vermani, K., and Garg, S., Drug Discov. Today 2002, 7 (10):569–579.
10.  Deshpande, A.A., Pharm. Res. 1997, 14 (6): 815–819.
11. Agyilirah, G.A.; Green, M.; DuCret, R., Int. J. Pharm. 1991, 75: 241–247.
12. Bechgaard, H.; Baggesen, S., J. Pharm. Sci. 1980, 69 (11): 1327–1330.
13. Devereux, J.E.; Newton, J.M.; Short, M.B., J. Pharm. Pharmacol. 1990, 42: 500–501.
14. Bardonnet, P.L., Faivre, V.. J. Cont. Rel, 2006, 111:1-18.
15. Wang, S.J., Park,H., Park,K., Crit. Rev. Ther. Drug Carrier Sys. 1998,15 (3),:243-284.
16. Sugito, K., Ogata, H., Goto, H., Noguchi, M., Kogure, T., Takano, M., Maruyama, Y.,Sasaki, Y. Int. J. Pharm. 1990, 60: 89–97.
17. Moes, A.J., Crit Rev Ther Drug Carrier Syst, 1993; 10(2): 143-195.
18. Swarbrick, J. and Boylan, J.C. Encyclopedia of Pharmaceutical Technology, Vol I, 2nd edition, published by Marcel Dekker, New York: 892-896.
19. Yeole, P.G., Khan, S., .Ind. J. Pharm. Sci. 2005; 67 (3): 265-272
20. Klausner, E.A., Hoffman, A.  J. Cont. Rel. 2003; 90: 143-162.
21. Salessiotis N, Am. J. Surg. 1972; 124: 331-333.

*Contents are provided by Authors of articles. Please contact us if you having any query.






Bank Details